Smoking at time of CIS increases the risk of clinically definite multiple sclerosis-Reference-Cited by-同舟云学术

Smoking at time of CIS increases the risk of clinically definite multiple sclerosis

Published:2018-02-20 Issue:5 Volume:265 Page:1010-1015
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

van der Vuurst de Vries Roos M.,Mescheriakova Julia Y.,Runia Tessel F.,Siepman Theodora A. M.,Wokke Beatrijs H. A.,Samijn Johnny P. A.,Hintzen Rogier Q.

Funder

the Dutch MS research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/article/10.1007/s00415-018-8780-4/fulltext.html

Reference33 articles.

1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517

2. Huynh JL, Casaccia P (2013) Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol 12(2):195–206

3. Frischer JM, Bramow S, Dal-Bianco A et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(Pt 5):1175–1189

4. Hedstrom AK, Hillert J, Olsson T, Alfredsson L (2013) Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 28(11):867–874

5. Handel AE, Williamson AJ, Disanto G et al (2011) Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 6(1):e16149

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review;Journal of Clinical Neuroscience;2024-04

2. Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?;Journal of Neuroinflammation;2024-01-17

3. The effects of different types of smoking on recovery from attack in hospitalized multiple sclerosis patients;Clinical Neurology and Neurosurgery;2023-09

4. Improving smoking cessation support for people with multiple sclerosis: A qualitative analysis of clinicians’ views and current practice;Multiple Sclerosis and Related Disorders;2021-11

5. Role of environmental factors in multiple sclerosis;Expert Review of Neurotherapeutics;2021-09-20